Acurx Pharmaceuticals (ACXP) Interest & Investment Income (2024 - 2026)
Acurx Pharmaceuticals' (ACXP) quarterly Interest & Investment Income came in at $35008.0 in Q1 2026, up 28.28% YoY from $27291.0 in Q1 2025, and down 9.87% on a QoQ basis from $38840.0 in Q4 2025.
Acurx Pharmaceuticals (ACXP) Interest & Investment Income (2024 - 2026) Analysis & Trends
Acurx Pharmaceuticals (ACXP) has 3 years of Interest & Investment Income data on file, last reported at $35008.0 in Q1 2026.
- Quarterly Interest & Investment Income rose 28.28% year-over-year to $35008.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $133163.0 (up 195.56% YoY) and the FY2025 annual result came in at $125445.0, up 523.36% from the prior year.
- Interest & Investment Income retreated to $35008.0 in Q1 2026, from $38840.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $38840.0 in Q4 2025 to a low of $782.0 in Q2 2024.
- A 3-year average of $22277.1 and a median of $25347.5 in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2025 — Interest & Investment Income soared 2892.84% — and 2026, when it rose 28.28%.
- Tracing ACXP's Interest & Investment Income over 3 years: stood at $11980.0 in 2024, then jumped by 224.21% to $38840.0 in 2025, then slipped by 9.87% to $35008.0 in 2026.
- The last three Interest & Investment Income figures came in at $35008.0 (Q1 2026), $38840.0 (Q4 2025), and $35911.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Acurx Pharmaceuticals | 6.38 Mn | 6.38 Mn | - | 53,055.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53,055.00 |
| Mar 31, 2026 | 35,008.00 |
| Dec 31, 2025 | 38,840.00 |
| Sep 30, 2025 | 35,911.00 |
| Jun 30, 2025 | 23,404.00 |
| Mar 31, 2025 | 27,291.00 |
| Dec 31, 2024 | 11,980.00 |
| Sep 30, 2024 | 5,001.00 |
| Jun 30, 2024 | 782.00 |